Continued Revenue Sharing. In the event the INSTITUTE receives during the Revenue Term the aggregate amount of […***…] percent ([…***…]%) of the Grant Award Proceeds from the RECIPIENT, the RECIPIENT will continue to pay the INSTITUTE a revenue sharing percentage of […***…] percent ([…***…]%) of Revenue for all Revenue generated during the remainder of the Revenue Term. For clarity, this revenue sharing percentage cannot be reduced as set forth in Section D4.01(b).
Appears in 2 contracts
Samples: Cancer Research Grant Contract, Cancer Research Grant Contract (Bellicum Pharmaceuticals, Inc)
Continued Revenue Sharing. In the event the INSTITUTE receives during the Revenue Term the aggregate amount of […[ ***…* ] percent ([…***…]%) of the Grant Award Proceeds from the RECIPIENT, the RECIPIENT will continue to pay the INSTITUTE a revenue sharing percentage of […[ ***…* ] percent ([…***…]%) of Revenue for all Revenue generated during the remainder of the Revenue Term. For clarity, this revenue sharing percentage cannot be reduced as set forth in Section D4.01(b).
Appears in 1 contract
Continued Revenue Sharing. In the event the INSTITUTE receives during the Revenue Term the aggregate amount of […***…] percent ([…***…]%) of the Grant Award Proceeds from the RECIPIENT, the RECIPIENT will continue to pay the INSTITUTE a revenue sharing percentage of […***…] percent ([…***…]%) of Revenue for all Revenue generated during the remainder of the Revenue Term. For clarity, this revenue sharing percentage cannot be reduced as set forth in Section D4.01(b).
Appears in 1 contract
Samples: Cancer Research Grant Contract (Aeglea BioTherapeutics, Inc.)
